Investing.com -- Shares of Verve Therapeutics (NASDAQ: VERV) surged 45% following the announcement of encouraging initial data from its Heart-2 Phase 1b clinical trial of VERVE-102, a gene-editing therapy aimed at reducing LDL cholesterol levels. The trial’s positive outcomes have heightened investor optimism, as the company revealed substantial LDL-C reductions and a favorable safety profile fo ...
Investing.com -- U.S. stock futures traded higher Monday as traders assess some temporary technology-related exemptions to President Donald Trump’s elevated “reciprocal” tariffs. Here are some of the biggest premarket U.S. stock movers today:Apple (NASDAQ:AAPL) stock gained 5.8%, Nvidia (NASDAQ:NVDA) rose 3.1%, and Dell Technologies (NYSE:DELL) gained 5.9% as these tech giants benefited from ...
Investing.com -- Shares of Polar Capital Holdings plc (LON:POLR) edged up by 1.5% despite the asset management firm reporting a contraction in assets under management (AUM) for the first quarter.The company’s AUM decreased by 10% quarter-over-quarter to £21.4 billion, falling short of the Visible Alpha consensus estimate by 7% but aligning with RBC Capital Markets expectations.The market’s re ...
By Barbara Erling and Amy-Jo CrowleyWARSAW (Reuters) -Warner Bros Discovery (NASDAQ:WBD) has decided not to sell Polish broadcaster TVN, it said on Monday, drawing a line under speculation surrounding the future of the company, which is considered strategic by the Polish government.The volatility unleashed by U.S. President Donald Trump’s tariff policies has led many investors to put deal-making ...